4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-103323
Chief Executive Officer sold 40,000 shares at an average $68.53 ($2,741,207)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-08-01 | Sale 10b5-1 | −16,745 | $67.81 | $1,135,416 | 2,884,625 | I: show line 1 in the form |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-08-01 | Sale 10b5-1 | −17,809 | $68.87 | $1,226,486 | 2,866,816 | I: show line 2 in the form |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-08-01 | Sale 10b5-1 | −5,446 | $69.65 | $379,305 | 2,861,370 | I: show line 3 in the form |
| Open-market sales · 40,000 sh · avg $68.53 · $2,741,207 | |||||||
Loading xslF345X05/ownership.xml…